Kazuya Yamano
Astellas Pharma (Japan)(JP)
Publications by Year
Research Areas
Cancer Mechanisms and Therapy, Peptidase Inhibition and Analysis, Cancer Research and Treatments, Monoclonal and Polyclonal Antibodies Research, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA(2004)174 cited
- → Establishment of the Anti-Klotho Monoclonal Antibodies and Detection of Klotho Protein in Kidneys(2000)162 cited
- → Comparison of cell lines for stable production of fucose‐negative antibodies with enhanced ADCC(2006)113 cited
- → Fucose content of monoclonal antibodies can be controlled by culture medium osmolality for high antibody-dependent cellular cytotoxicity(2011)47 cited
- An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models.(2018)
- Anti-tumor efficacy evaluation of a novel monoclonal antibody targeting neutral amino acid transporter ASCT2 using patient-derived xenograft mouse models of gastric cancer.(2017)
- → SUG1, a Component of the 26 S Proteasome, Is an ATPase Stimulated by Specific RNAs(1997)28 cited
- → Structures of the Rat Proteasomal ATPases: Determination of Highly Conserved Structural Motifs and Rules for Their Spacing(1996)25 cited
- → Human adenosine A3 receptor leads to intracellular Ca2+ mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase γ in mice(2005)16 cited
- → Identification of the functional expression of adenosine A3 receptor in pancreas using transgenic mice expressing jellyfish apoaequorin(2007)14 cited